Intelligence · Clinical Pipeline

Boehringer Ingelheim Pipeline

All ClinicalTrials.gov programs at Boehringer Ingelheim — phase, modality, and trial IDs.

Programs: 193

Quick answer

Boehringer Ingelheim has 193 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

A study in healthy men and women to test how BI 3000202 is taken up and processed by the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men and women to test whether BI 1569912 influences the amount of repaglinide, midazolam and bupropion in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how BI 1569912 is processed in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how BI 1584862 is processed in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how BI 1839100 is taken up and handled by the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how bosentan influences the amount of nerandomilast in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how bosentan influences the amount of zongertinib in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how different doses of BI 3031185 are tolerated and how food influences the amount of BI 3031185 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how itraconazole influences the amount of BI 764198 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how well different doses of BI 3731579 are tolerated

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how well different doses of BI 3776528 are tolerated

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test how well different doses of BI 3821001 are tolerated

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test whether BI 1815368 influences the amount of metformin in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test whether esomeprazole influences the amount of BI 3000202 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test whether food influences the amount of BI 3731579 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood

Boehringer Ingelheim

Pharmacokinetic trial

phase 1 other active

1 trial
A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furosemide) in the blood

Boehringer Ingelheim

Pharmacokinetic trial

phase 1 other active

1 trial
A study in healthy people or otherwise healthy but overweight or obese to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injector

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people or otherwise healthy with overweight or obesity to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injector

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to compare how 2 different formulations of survodutide are taken up by the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body

Boehringer Ingelheim

Pharmacokinetic trial

phase 1 other active

1 trial
A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body

Boehringer Ingelheim

Pharmacokinetic trial

phase 1 other active

1 trial
A study in healthy people to compare how 3 different formulations of survodutide are taken up in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to compare two different Sifrol® tablets

Boehringer Ingelheim

Pharmacokinetic trial

phase 1 other active

1 trial
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to compare two tablet formulations of pramipexole

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to see how zongertinib is taken up into the blood when given as tablets made by two different manufacturers

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how 2 different doses of BI 1291583 are taken up in the body when given in 3 different formulations.

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how 2 different formulations of BI 690517 are taken up in the body and how probenecid influences the amount of BI 690517 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food

Boehringer Ingelheim

healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how itraconazole influences the amount of BI 3031185 in the blood

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how vicadrostat affects the heart

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazolam

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test whether BI 1291583 influences the amount of dabigatran in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test whether BI 3000202 affects how 2 other medicines (rosuvastatin and digoxin) are taken up in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test whether BI 764198 influences the amount of metformin in the body

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in healthy people to test whether erythromycin influences the amount of BI 1291583 in the blood.

Boehringer Ingelheim

Healthy volunteer trial

phase 1 other active

1 trial
A study in patients with different types of advanced cancer (solid tumors) to test different doses of BI 907828 (brigimadlin) in combination with BI 754091 (ezabenlimab) and BI 754111 or BI 907828 (brigimadlin) in combination with BI 754091 (ezabenlimab)

Boehringer Ingelheim

advanced solid tumors

phase 1 other active

1 trial
A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps

Boehringer Ingelheim

Melanoma, Solid tumours

phase 1 other active

1 trial
A study in people with advanced cancer to test how well different doses of BI 3819026 are tolerated when taken alone and together with ezabenlimab

Boehringer Ingelheim

unresectable advanced or metastatic solid cancer

phase 1 other active

1 trial
A study in people with advanced cancer to test whether the amount of BI 907828 in the blood is influenced by taking an OATP inhibitor or a CYP3 inhibitor

Boehringer Ingelheim

Solid cancer tumors

phase 1 other active

1 trial
A study in people with obesity to test the effects of different doses of BI 456906 compared with semaglutide on glucagon receptor activity in the liver

Boehringer Ingelheim

No targeted indication. Male and female subjects with obesity.

phase 1 other active

1 trial

Frequently asked questions

How many pipeline programs does Boehringer Ingelheim have?

193 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Quick answer

A study in healthy men and women to test how BI 3000202 is taken up and processed by the body

A study in healthy men and women to test whether BI 1569912 influences the amount of repaglinide, midazolam and bupropion in the blood

A study in healthy men to compare the amount of vicadrostat and empagliflozin in the blood when taken separately and together

A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood

A study in healthy men to test how BI 1569912 is processed in the body

A study in healthy men to test how BI 1584862 is processed in the body

A study in healthy men to test how BI 1839100 is taken up and handled by the body

A study in healthy men to test how bosentan influences the amount of nerandomilast in the blood

A study in healthy men to test how bosentan influences the amount of zongertinib in the blood

A study in healthy men to test how different doses of BI 3031185 are tolerated and how food influences the amount of BI 3031185 in the blood

A study in healthy men to test how itraconazole influences the amount of BI 764198 in the blood

A study in healthy men to test how well different doses of BI 3731579 are tolerated

A study in healthy men to test how well different doses of BI 3776528 are tolerated

A study in healthy men to test how well different doses of BI 3821001 are tolerated

A study in healthy men to test whether BI 1815368 influences the amount of metformin in the body

A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood

A study in healthy men to test whether esomeprazole influences the amount of BI 3000202 in the blood

A study in healthy men to test whether food influences the amount of BI 3731579 in the blood

A study in healthy men to test whether zongertinib influences the amount of 3 other medicines in the blood

A study in healthy men to test whether zongertinib influences the amount of 4 other medicines (dabigatran, rosuvastatin, metformin, and furosemide) in the blood

A study in healthy people or otherwise healthy but overweight or obese to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injector

A study in healthy people or otherwise healthy with overweight or obesity to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injector

A study in healthy people to compare how 2 different formulations of survodutide are taken up by the body

A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body

A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body

A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body

A study in healthy people to compare how 3 different formulations of survodutide are taken up in the body

A study in healthy people to compare two different Sifrol® tablets

A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood

A study in healthy people to compare two tablet formulations of pramipexole

A study in healthy people to see how zongertinib is taken up into the blood when given as tablets made by two different manufacturers

A study in healthy people to test how 2 different doses of BI 1291583 are taken up in the body when given in 3 different formulations.

A study in healthy people to test how 2 different formulations of BI 690517 are taken up in the body and how probenecid influences the amount of BI 690517 in the blood

A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food

A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food

A study in healthy people to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food

A study in healthy people to test how itraconazole influences the amount of BI 3031185 in the blood

A study in healthy people to test how vicadrostat affects the heart

A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazolam

A study in healthy people to test whether BI 1291583 influences the amount of dabigatran in the body

A study in healthy people to test whether BI 3000202 affects how 2 other medicines (rosuvastatin and digoxin) are taken up in the body

A study in healthy people to test whether BI 764198 influences the amount of metformin in the body

A study in healthy people to test whether erythromycin influences the amount of BI 1291583 in the blood.

A study in patients with different types of advanced cancer (solid tumors) to test different doses of BI 907828 (brigimadlin) in combination with BI 754091 (ezabenlimab) and BI 754111 or BI 907828 (brigimadlin) in combination with BI 754091 (ezabenlimab)

A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps

A study in people with advanced cancer to test how well different doses of BI 3819026 are tolerated when taken alone and together with ezabenlimab

A study in people with advanced cancer to test whether the amount of BI 907828 in the blood is influenced by taking an OATP inhibitor or a CYP3 inhibitor

A study in people with obesity to test the effects of different doses of BI 456906 compared with semaglutide on glucagon receptor activity in the liver

Frequently asked questions

Stay Ahead in Pharma